KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Change in Cash (2016 - 2025)

Historic Change in Cash for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $43.6 million.

  • Idexx Laboratories' Change in Cash rose 14687.48% to $43.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.5 million, marking a year-over-year decrease of 33568.95%. This contributed to the annual value of -$165.7 million for FY2024, which is 14852.75% down from last year.
  • Idexx Laboratories' Change in Cash amounted to $43.6 million in Q3 2025, which was up 14687.48% from $624000.0 recorded in Q2 2025.
  • Idexx Laboratories' Change in Cash's 5-year high stood at $198.9 million during Q3 2023, with a 5-year trough of -$124.3 million in Q1 2025.
  • In the last 5 years, Idexx Laboratories' Change in Cash had a median value of -$1.2 million in 2023 and averaged -$9.3 million.
  • Its Change in Cash has fluctuated over the past 5 years, first soared by 188504.67% in 2022, then crashed by 469211.2% in 2024.
  • Over the past 5 years, Idexx Laboratories' Change in Cash (Quarter) stood at -$749000.0 in 2021, then soared by 1885.05% to $13.4 million in 2022, then surged by 814.26% to $122.2 million in 2023, then tumbled by 116.66% to -$20.4 million in 2024, then skyrocketed by 313.9% to $43.6 million in 2025.
  • Its Change in Cash was $43.6 million in Q3 2025, compared to $624000.0 in Q2 2025 and -$124.3 million in Q1 2025.